Point of Care Diagnostics Point Of Care Diagnostics Market

Point of Care Diagnostics Market

Point of Care Diagnostics Market by kits Product (Glucose Monitoring, Infectious Disease Testing, Pregnancy And Fertility Testing, Hematology Testing, Cardiometabolic Monitoring, Urinalysis Testing, Coagulation Monitoring, Tumor Markers Testing, Cholesterol Test Strips, Drugs Of Abuse Testing, and Fecal Occult Testing), Platform (Microfluidics and Immunoassay), End-user (Hospital, E-comm, and Home Care) and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 01-Mar-2022 Category: Healthcare Report Format : PDF Pages: 187 Report Code: ZMR-812 Status : Published

The global point of care diagnostics market size was worth around USD 35.4 billion in 2021 and is estimated to grow to about USD 62.1 billion by 2028, with a compound annual growth rate (CAGR) of approximately 11.5 percent over the forecast period.

Point of Care Diagnostics Market

Point of Care Diagnostics Market: Industry Prospective

The global point of care diagnostics market was worth around USD 35.4 billion in 2021 and is estimated to grow to about USD 62.1 billion by 2028, with a compound annual growth rate (CAGR) of approximately 11.5 percent over the forecast period. The report analyzes the point of care diagnostics market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the point of care diagnostics market.

Point of Care Diagnostics Market: Overview

Point-of-care diagnostics (POCD) is critical for detecting analytes close to the patient, allowing for improved illness monitoring, diagnosis, and management. It allows for rapid medical choices since illnesses can be detected at an early stage, resulting in better health outcomes for patients by allowing for the early initiation of therapy.

COVID-19 Impact:

The role of point-of-care diagnostic during the pandemic was crucial. The need for POC tests increased double-fold resulting in sharp growth of the global point of care diagnostics market from mid-2020 to 2021. Since the severe acute respiratory syndrome (SARS-CoV-2) virus jumped from an animal population to humans in December 2019, it has quickly spread around the world, posing critical public health challenges such as becoming the leading cause of death in the U.S. in early 2021, disrupting daily life, and causing economic losses to firms & people. The COVID-19 pandemic has underlined the importance of swiftly and properly diagnosing the disease at bigger scales than ever before. Models suggest that millions of tests per day are required to fully remobilize the economy. However, numerous issues have led to less-than-ideal testing availability, including a lack of laboratory supplies (which also affects non-COVID testing) and test kits.

These facts suggest the demand for point of care diagnostics is expected to remain high during the forecast period. Also, increased awareness about POC diagnostic among the patients may increase its adoption in emerging countries.

Global pea protein market

Point of Care Diagnostics Market: Growth Drivers

Rise in prevalence of infectious and chronic diseases is fostering the market growth

Globally, the burden of infectious and chronic diseases is on the rise. Lack of exercise, changes in lifestyle, and unhealthy habits are also some of the factors that are leading to an increase in chronic diseases like diabetes, chronic respiratory diseases, and cardiovascular diseases. According to WHO, cardiovascular disease constitutes the majority of non-communicable diseases mortality (17.9 million per year), followed by cancer (9.3 million), respiratory infections (4.1 million), and diabetes (1.5 million). Additionally, two-thirds of all tuberculosis cases worldwide were traced to just eight countries: South Africa, Bangladesh, Nigeria, Pakistan, the Philippines, China, Indonesia, and India. POC diagnostics can considerably enhance the treatment of infectious illnesses, particularly in underdeveloped nations where prompt medical care is difficult to come by and healthcare infrastructure is limited. Furthermore, government incentives and grants for the introduction of new products are driving the use of modern technology for infectious disease diagnostics. These efforts have made it simpler for people in undeveloped and impoverished nations to afford these tests. Moreover, factors such as the increasing number of clinics implementing POC diagnostics for the quick identification of infectious diseases are likely to fuel the growth of the global point of care diagnostics market.

Point of Care Diagnostics Market: Restraints

Lack of trained professionals in the diagnostic field to hamper market growth.

According to WHO research, a worldwide health concern is a shortage of healthcare workers, which affects access to healthcare services. Low- and middle-income countries are further hampered by a shortage of trained health professionals, and new innovations, such as the adoption of POC diagnostics in medical care, are posing challenges to POCT delivery due to the increasing workload and dearth of skilled health workers.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Point of Care Diagnostics Market: Opportunities

Smart devices equipped with mobile healthcare (mH) to pave way for market expansion

The current POCD trend is firmly leaning toward smart devices integrated with mobile healthcare, which have the potential to genuinely transform customized healthcare monitoring and management, opening the way for next-generation point of care diagnostics. Smartphone POC technologies for the interpretation of colorimetric, chemiluminescent, fluorescence, electrochemical, label-free, and lateral flow assays detection of cells, nanoparticles, biomolecules, and microbes; and other diagnostic applications have previously been developed. The number of cellphone users has now surpassed 7.4 billion, with 70 percent of them living in poor nations with a severe need for POCD. Numerous smartphone gadgets and smart applications for managing and monitoring fundamental health metrics such as blood pressure, blood glucose, pulse rate, body analysis, physical activity, weight, and electrocardiogram have been commercialized. All these factors ensure the healthy growth of the global point of care diagnostics market during the forecast period.

Point of Care Diagnostics Market: Challenges.

Market is likely to face challenges due to high test cost compared to laboratory tests

One of the major challenges for the global point of care diagnostics market is its high cost as compared to laboratory tests. Rural areas and underdeveloped nations still prefer laboratory testing over POC diagnostics which in turn is limiting the market growth. Also, unfavorable reimbursement policies for POC diagnostics have led to low penetration of the market in emerging countries.

Point of Care Diagnostics Market: Segmentation

The global point-of-care diagnostics market is categorized based on kits product, platform, end-user, and region. Based on the kits product, the global market is bifurcated into infectious disease testing, glucose monitoring, pregnancy & fertility testing, cardiometabolic monitoring, hematology testing, urinalysis testing, coagulation monitoring, cholesterol test strips, tumor markers testing, fecal occult testing, and drugs of abuse testing. Among these, the glucose monitoring segment dominates the market with more than 25 percent of the share. By platform, the market is segregated as microfluidics and immunoassay. The end-user segment of the global market is divided into hospital, home care, and e-comm. In end-users, the home care segment is expected to register the fastest growth during the forecast period.

Recent Developments

On 23 September 2021, Celltrion, a specialist biologics firm, stated that the Department of Defense's Defense Logistics Agency (DLA) has granted Celltrion USA, Inc., a Celltrion affiliate, a purchase agreement for its DiaTrustTM COVID-19 Ag Rapid Test.

Point of Care Diagnostics Market: Regional Landscape

North America is expected to remain the largest market for point of care diagnostics during the forecast period. Key factors propelling the growth of the market in the region include an increase in the upper-class population, increasing cases of chronic disorders due to changes in food habitats & lifestyle, and growing demand for effective and efficient diagnostics. Further, healthcare infrastructure in major countries in the region such as the US and Canada is well developed and supports advanced treatment & diagnostics systems. Moreover, high spending power on medical treatments is well supported by increasing initiatives by private and public hospitals in the region. Asia Pacific is projected to provide plenty of opportunities for the expansion of the point of care diagnostics market. Large middle-class populations with frequent health problems are triggering the need for efficient diagnostic systems. Besides, increasing awareness regarding POC diagnostics in emerging countries such as India and China is expected to fuel the market growth over the forecast period.

Point of Care Diagnostics Market: Competitive Landscape

Key players with a major share in the global point of care diagnostics market include Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Danaher Corporation, Abbott Laboratories, Chembio Diagnostics, and Quidel Diagnostics. Other prominent players operating in this market are Trinity Biotech, EKF Diagnostics, and Fluxergy.

Global point of care diagnostics market is segmented as follows:

By Kits Product

  • Glucose monitoring kits
  • Infectious disease testing kits
  • Pregnancy and fertility testing kits
  • Hematology testing kits
  • Cardiometabolic monitoring kits
  • Urinalysis Testing Kits
  • Coagulation Monitoring Kits
  • Tumor Markers Testing Kits
  • Cholesterol Test Strips
  • Drugs of Abuse Testing Kits
  • Fecal Occult Testing Kits
  • Others (Calcium Assay Kits and Immunochemistry Kits)

By Platform

  • Microfluidics
  • Immunoassay

By End Users

  • Rural Hospital
  • Home Care
  • E-comm

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

 

Table Of Content

Methodology

Free Analysis

FrequentlyAsked Questions

Increasing burden of infectious and chronic diseases due to lack of exercise, changes in lifestyle, and unhealthy habits are also some of the factors that are leading to an increase in chronic diseases like diabetes, chronic respiratory diseases, and cardiovascular diseases which is primarily fueling the demand for point of care diagnostics.

 

According to the Zion Market Research report, the global point of care diagnostics market was worth about 35.4 (USD billion) in 2021 and is predicted to grow to around 62.1 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 11.5 percent.

 

North America is expected to remain the largest market for point of care diagnostics during the forecast period. Key facts propelling the growth of the market in the region include increase in the upper-class population, increasing cases of chronic disorders due to changes in food habitats and lifestyle, and growing demand for effective and efficient diagnostics.

 

Key players with a major share in the global point of care diagnostics market include Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Danaher Corporation, Abbott Laboratories, Chembio Diagnostics, and Quidel Diagnostics. Other prominent players operating in this market are Trinity Biotech, EKF Diagnostics, and Fluxergy.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed